sameAs
P26
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective dataAntivirals for influenza: where now for clinical practice and pandemic preparedness?Current research on respiratory viral infections: Fourth International Symposium.Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK.Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak.Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) diseasePredominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung.Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis.Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responsesPulmonary defences to acute respiratory infection.IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in miceImmunity to RSV in Early-Life.Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cellsRespiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003.The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection.Current concepts and progress in RSV vaccine development.Antiviral B cell and T cell immunity in the lungs.Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.Development of vaccines against common colds.Protective and dysregulated T cell immunity in RSV infectionPrior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent mannerRole of CCL5 (RANTES) in viral lung disease.A gene expression signature for RSV: clinical implications and limitations.OX40 ligand and programmed cell death 1 ligand 2 expression on inflammatory dendritic cells regulates CD4 T cell cytokine production in the lung during viral disease.Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune ResponsivenessRespiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.Antiviral immune responses and lung inflammation after respiratory syncytial virus infection.Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease developmentEndogenous IL-21 regulates pathogenic mucosal CD4 T-cell responses during enhanced RSV disease in miceDifferences between asthmatics and nonasthmatics hospitalised with influenza A infection.Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection.Emerging drugs for respiratory syncytial virus infection.
P50
Q24632365-23D7F8B2-0785-42F6-B7BC-128B7A9CA26BQ28730789-B8DCDFB2-A730-4B39-9BC5-4538328A108CQ30210112-C7766841-8E71-4BB0-9582-C7DDF04A7509Q30309620-5F6A2535-DD3E-4DA1-BA4F-4670C7817789Q30365369-7A459139-77E2-4559-8EAC-106A5F898783Q30366662-AC05CA23-4D17-49D6-BEF3-AB4997FF5BB6Q30390413-EE676544-0D7C-4441-A4A0-CCA319ECFBA0Q30398779-463B853B-6636-4DC2-A99A-23842C87A80EQ30402302-FE08D1F5-A966-422F-892C-1C3C98508DC1Q30418993-7F9B9592-0CEB-464A-939C-33FFE9361BDFQ33535780-09869A68-988A-4CB2-AB21-87F04A337E1DQ33717513-28512441-0A4F-498A-B397-6B0FEF5CD62FQ33812212-185555E7-CD37-433A-AF61-0EC39DE5F555Q34127337-238C3F10-A0DE-4E4F-BE26-B58322FAE161Q34185860-25A5B1BA-D236-4408-A502-60C87C62B1C8Q34264615-BC1C9884-6CC9-44F7-B371-F326B702D964Q34326260-2CE0EC79-A6E4-457C-9996-040DA5E36553Q34364454-0BEA57BF-5377-46A2-8892-19186E6A90F2Q34369010-E0B1358B-9FB3-4302-ABC3-CAAF7638115BQ34396689-043E2AC1-B5B4-47A1-BC3F-467EED35EA83Q34454614-9C529A21-324D-4632-AC83-417A2728B602Q34647519-310BE496-7B32-4BCB-B769-DF0B79C4D9AEQ34784875-6670B291-8881-4DBC-8470-6B50B61F594CQ34964939-6406B62B-044B-439D-A308-4B2E039E0552Q35011426-2454D67C-CE75-4CC2-A90D-8386C87C0B82Q35024052-82A2E94E-0341-41B6-B4D4-D1852A1ADCF6Q35050237-4B2FD5A0-84AB-432A-A115-055C612BAE86Q35748934-97025FF2-439E-4A29-9EDE-CE7D682667D1Q35765491-3A271DBD-6268-4F46-BB33-701016EA7B5AQ35772526-160578E4-9E1D-4092-94C3-A917E8DF95D3Q36064557-2BE3ED9C-CD3E-4A73-9375-3F6BCF70D1A9Q36113037-06D7A43D-8B82-4283-B01B-7701ACD5AEF3Q36237032-750AB20C-F2ED-438D-AB7E-4803C1AC050DQ36276582-118D4FA6-86D6-49C9-B20F-0EB32FE6313DQ36438145-6787C734-576A-4430-A766-D7DCA2C34FE7Q36540154-2E4D8F33-3CE7-4885-AFD9-AC3AA05EB394Q36723988-47BA01F6-C46B-43B3-844E-F805591D9B50Q36729465-298DDD71-2C4C-4A23-B051-F6116B7A5B2BQ36747814-0ABCC817-942C-4812-AD92-64FA0A09AE03Q37250650-5675483C-88D7-4DC8-A9C3-88305B7DB2BD
P50
description
British physician
@en
British physician
@en-ca
British physician
@en-gb
Suurbritannia arst
@et
inmunólogu británicu
@ast
medic britanic
@ro
medico britannico
@it
metge britànic
@ca
mjek britanik
@sq
médecin britannique
@fr
name
Peter Openshaw
@ast
Peter Openshaw
@ca
Peter Openshaw
@de
Peter Openshaw
@en
Peter Openshaw
@es
Peter Openshaw
@fr
Peter Openshaw
@nl
Peter Openshaw
@sl
پیتر اپنساوا
@azb
type
label
Peter Openshaw
@ast
Peter Openshaw
@ca
Peter Openshaw
@de
Peter Openshaw
@en
Peter Openshaw
@es
Peter Openshaw
@fr
Peter Openshaw
@nl
Peter Openshaw
@sl
پیتر اپنساوا
@azb
altLabel
Peter J Openshaw
@ast
Peter J Openshaw
@en
Peter J Openshaw
@nl
Peter John Morland Openshaw
@en
prefLabel
Peter Openshaw
@ast
Peter Openshaw
@ca
Peter Openshaw
@de
Peter Openshaw
@en
Peter Openshaw
@es
Peter Openshaw
@fr
Peter Openshaw
@nl
Peter Openshaw
@sl
پیتر اپنساوا
@azb
P166
P214
P244
P101
P106
P19
P21
P214
P244
n2017188163
P26
P31
P496
0000-0002-7220-2555
P551
P569
1947-11-11T00:00:00Z
P735
P7859
lccn-n2017188163